
Join to View Full Profile
8440 Walnut Hill LnSte 600Dallas, TX 75231
Phone+1 214-739-1706
Fax+1 214-368-0056
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gabriel Shapiro, MD is an oncologist in Dallas, Texas. He is currently licensed to practice medicine in Texas. He is a Clinical Assistant Professor at University of Texas.
Education & Training
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1974 - 1974
- University of Texas Southwestern Medical CenterResidency, Psychiatry, 1969 - 1973
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1971 - 1972
- Duke University HospitalResidency, Internal Medicine, 1969 - 1971
- University of Oklahoma College of MedicineClass of 1969
Certifications & Licensure
- TX State Medical License 1972 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsFirst-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma: A Case ReportBao D. Dao, Ildiko Lingvay, Joseph L. Sailors, Michael J Landay, Gabriel A. Shapiro
Journal of Investigative Medicine High Impact Case Reports. 2015-07-01 - 6 citationsAntiphospholipid syndrome in obstetrics and gynecology.Gabriel Shapiro
Seminars in Thrombosis and Hemostasis. 1994-01-01
Press Mentions
- Blockchain Bites: ‘Immunity Passports,’ a Darknet Pharmacist and How Bitcoin Miners Prepare for the HalvingApril 13th, 2020
- Making Sense of the SEC’s Case Against TelegramApril 12th, 2020
- Judge Denies Telegram’s Request to Issue Gram Tokens to Non-US InvestorsApril 1st, 2020
- Join now to see all